Lymphangioma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Badria Munir (talk | contribs) |
Shyam Patel (talk | contribs) |
||
| (12 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphangioma}} | {{Lymphangioma}} | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{Badria}} {{HL}} | ||
==Overview== | ==Overview== | ||
* There is no medical treatment for lymphangioma | * There is no particular medical treatment for [[lymphangioma|lymphangioma]]. The mainstay of therapy is surgery. | ||
==Medical Therapy== | ==Medical Therapy== | ||
There is no medical treatment for lymphangioma | There is no particular medical treatment for [[lymphangioma]]. The mainstay of therapy is surgery: | ||
* However, [[propranolol]] is a potential option, which can be used in intractable [[lymphangiomatosis]].<ref name="pmid1533">{{cite journal |vauthors=Sack M, Cassidy JT, Bole GG, Vinar O |title=Prognostic factors in polyarteritis |journal=J. Rheumatol. |volume=2 |issue=4 |pages=411–20 |date=December 1975 |pmid=1533 |doi= |url=}}</ref> | |||
* [[Sodium tetradecyl sulfate]] is an off-label option for treatment of [[lymphangioma circumscriptum]].<ref name="pmid1524">{{cite journal |vauthors=Moos F, Richard P, Sugiura M, Iwasaki K, Kato R |title=[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)] |language=French |journal=J. Physiol. (Paris) |volume=70 |issue=3 |pages=315–32 |date=November 1975 |pmid=1524 |doi= |url=}}</ref> | |||
Other therapies include:<ref name="pmid5556746">{{cite journal |vauthors=Rajasingham R, Bell JL, Baron DN |title=A comparative study of the isoenzymes of mammalian alpha-amylase |journal=Enzyme |volume=12 |issue=2 |pages=180–6 |date=1971 |pmid=5556746 |doi= |url=}}</ref> | |||
* Destructive treatments with [[Carbon dioxide|carbon dioxide (CO2)]] [[laser]] | |||
* Long-pulsed Nd-YAG [[laser]] | |||
* [[Electrosurgery]] | |||
* [[Cryotherapy]] | |||
* Superficial [[radiotherapy]] [[sclerotherapy]] with 23.4% [[hypertonic]] [[saline]] | |||
* Direct injection of a sclerosing agent, including 1% or 3% [[sodium tetradecyl sulfate]], [[doxycycline]] or [[ethanol]] | |||
==References== | ==References== | ||
Latest revision as of 04:42, 10 February 2019
|
Lymphangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangioma medical therapy On the Web |
|
American Roentgen Ray Society Images of Lymphangioma medical therapy |
|
Risk calculators and risk factors for Lymphangioma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] Haytham Allaham, M.D. [3]
Overview
- There is no particular medical treatment for lymphangioma. The mainstay of therapy is surgery.
Medical Therapy
There is no particular medical treatment for lymphangioma. The mainstay of therapy is surgery:
- However, propranolol is a potential option, which can be used in intractable lymphangiomatosis.[1]
- Sodium tetradecyl sulfate is an off-label option for treatment of lymphangioma circumscriptum.[2]
Other therapies include:[3]
- Destructive treatments with carbon dioxide (CO2) laser
- Long-pulsed Nd-YAG laser
- Electrosurgery
- Cryotherapy
- Superficial radiotherapy sclerotherapy with 23.4% hypertonic saline
- Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol
References
- ↑ Sack M, Cassidy JT, Bole GG, Vinar O (December 1975). "Prognostic factors in polyarteritis". J. Rheumatol. 2 (4): 411–20. PMID 1533.
- ↑ Moos F, Richard P, Sugiura M, Iwasaki K, Kato R (November 1975). "[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)]". J. Physiol. (Paris) (in French). 70 (3): 315–32. PMID 1524.
- ↑ Rajasingham R, Bell JL, Baron DN (1971). "A comparative study of the isoenzymes of mammalian alpha-amylase". Enzyme. 12 (2): 180–6. PMID 5556746.